These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9213095)

  • 1. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome.
    Després JP
    Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin resistance in childhood obesity.
    Caprio S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():487-92. PubMed ID: 12017221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity: epidemiology and clinical aspects.
    Formiguera X; Cantón A
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1125-46. PubMed ID: 15561643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)].
    Farnier M
    Arch Mal Coeur Vaiss; 2007 Dec; 100(12):979-84. PubMed ID: 18223510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and hypertension in the absence of subcutaneous fat.
    Chaudhuri A; Izzo JL
    Rev Cardiovasc Med; 2000; 1(2):120-4. PubMed ID: 12457148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers.
    Toh SA; Rader DJ
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1007-22. PubMed ID: 18666851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
    Després JP
    Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The obesity epidemic: pathophysiology and consequences of obesity.
    Pi-Sunyer FX
    Obes Res; 2002 Dec; 10 Suppl 2():97S-104S. PubMed ID: 12490658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity: a main factor of metabolic syndrome?
    Licata G; Argano C; Di Chiara T; Parrinello G; Scaglione R
    Panminerva Med; 2006 Jun; 48(2):77-85. PubMed ID: 16953145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome.
    Garber AJ
    Med Clin North Am; 2004 Jul; 88(4):837-46, ix. PubMed ID: 15308381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese.
    Thomas GN; Ho SY; Lam KS; Janus ED; Hedley AJ; Lam TH;
    Obes Res; 2004 Nov; 12(11):1805-13. PubMed ID: 15601976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.